To further assess whether cDC2, cDC1, and Mo in pSS patients may differ on the activation of specific antiviral or IFN‐related pathways, we analyzed by RNA‐seq the differential transcriptional patterns of these cell subsets from PB of n = 4 pSS patients and n = 4 HD. This evidence concerns the gene IFNA1 and Huntington disease.